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Chromatin remodeling and histone modifications facilitate access of transcription factors to DNA by
promoting the unwinding and destabilization of histone–DNA interactions. We present DPF3, a new
epigenetic key factor for heart and muscle development characterized by a double PHD finger. DPF3 is
associated with the BAF chromatin remodeling complex and binds methylated and acetylated lysine residues
of histone 3 and 4. Thus, DPF3 may represent the first plant homeodomains that bind acetylated lysines, a
feature previously only shown for the bromodomain. During development Dpf3 is expressed in the heart and
somites of mouse, chicken, and zebrafish. Morpholino knockdown of dpf3 in zebrafish leads to incomplete
cardiac looping and severely reduced ventricular contractility, with disassembled muscular fibers caused by
transcriptional deregulation of structural and regulatory proteins. Promoter analysis identified Dpf3 as a novel
downstream target of Mef2a. Taken together, DPF3 adds a further layer of complexity to the BAF complex by
representing a tissue-specific anchor between histone acetylations as well as methylations and chromatin
remodeling. Furthermore, this shows that plant homeodomain proteins play a yet unexplored role in recruiting
chromatin remodeling complexes to acetylated histones.
[Keywords: Heart and skeletal muscle development and function; PHD finger; BAF chromatin remodeling
complex; SMARCD3–BAF60; acetylated and methylated histones; Mef2]
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Complex transcription networks mediate cell specifica-
tion, proliferation, and differentiation throughout devel-
opment and life. Coordinated activation and repression
of different subsets of genes is regulated at several levels
by genetic and epigenetic mechanisms. Genomic DNA
is packaged into nucleosomes, the basic unit of chroma-
tin structure formed by DNA wrapped around a histone
octamer. Chromatin remodeling and covalent histone
modifications facilitate DNA access for DNA-binding
transcription factors (Simone 2006; Bernstein et al. 2007;
Sperling 2007). Specific patterns of histone tail modifi-
cations attract or repel regulatory proteins of the chro-
matin remodeling complex. Histone modifications can
influence one another and thus not just the level of
modification but also the pattern may dictate biological
outcome (Fischer et al. 2008).
The main histone modifications are acetylation and
methylation. Recently, several transcription or remodel-
ing factors (e.g., TFIID, BPTF, Yng2) have been identified,
which bind to methylated histone lysine residues via
different domains, such as WD-40, Tudor, MBT, and the
plant homeodomain (PHD) (Kim et al. 2006; Ruthenburg
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et al. 2007; Vermeulen et al. 2007). Acetylation of his-
tone lysine residues by histone acetyltransferases
(HATs) stimulates gene expression by recruiting chro-
matin remodeling complexes and neutralizing positive
charge, resulting in destabilization of histone–histone
and histone–DNA interactions that limit access of tran-
scription factors to DNA. The effect of HATs is coun-
teracted by histone deacetylases (HDACs), and repre-
sents a control point of gene expression exemplified by
cardiac growth in response to acute and chronic stress
stimuli (Backs and Olson 2006). The recruitment of re-
modeling complexes is highly affected by histone acety-
lation and the bromodomain is the only protein domain
that is presently known to recognize acetylated lysine
residues of histones (Mujtaba et al. 2007). Surprisingly,
bromodomains can be dispensable in vivo, which sug-
gests functional redundancy among proteins (Elfring et
al. 1998; Bourachot et al. 1999; Hassan et al. 2002;
Mohrmann and Verrijzer 2005). Chromatin remodeling
complexes use free energy derived from ATP hydrolysis
to actively alter nucleosomal structure. These factors
peel DNA from the edge of the nucleosomes forming a
DNA loop or slide the histone octamer to a different
position (Kassabov et al. 2003). Different chromatin re-
modeling complexes have been identified (e.g., SWR/
NURF, CHD/NuRD, or SWI/SNF), which are defined by
a unique subunit composition and the presence of a dis-
tinct ATPase (Palacios and Puri 2006; Simone 2006; Bao
and Shen 2007). Mammalian SWI/SNF-like complexes
(BAF complexes) are characterized by central core sub-
units BRG1 and BRM and 10 further subunit elements;
e.g., SMARCD3 (BAF60c) representing a muscle-specific
component. BRG1 and BRM contain an ATPase domain
and a bromodomain that recognizes acetylated lysine in
histone tails and other proteins (Sif 2004; Simone 2006).
Thus, BRG1 acts as a ubiquitously expressed targeting
molecule to anchor chromatin remodeling complexes on
promoters with particular histone modification marks
(Hassan et al. 2002, 2007). SMARCD3 is a promiscuous
partner for several DNA-binding transcription factors,
including nuclear receptors PPAR, RXR, RAR, and
muscle regulatory factors like MEF2, MyoD, Nkx2.5,
Tbx5, and Gata4 (Debril et al. 2004; Lickert et al. 2004;
Palacios and Puri 2006; Simone 2006; Flajollet et al.
2007; Z.Y. Li et al. 2007). Tissue-specific transcription
can be initiated by ligand-dependent activation of signal-
ing cascades; e.g., phosphorylation of SMARCD3 and
MEF2 through p38 MAP-kinase leads to translocation of
MEF2 to the nucleus, potentially enhances their inter-
action, and finally, the BAF complex is targeted to
muscle-specific loci (Simone et al. 2004; Rauch and
Loughna 2005).
In the early mouse embryo Smarcd3 is specifically ex-
pressed in heart and somites, and is required for cardiac
looping and outflow tract development. Smarcd3-defi-
cient mice furthermore show impaired trabeculation of
the heart and disorganized somites (Lickert et al. 2004;
Takeuchi et al. 2007). The four Mef2 transcription fac-
tors (Mef2a, Mef2b, Mef2c, and Mef2d) regulate muscle
cell differentiation, and can, in part, compensate each
other’s function (Karamboulas et al. 2006). Mef2s are
DNA-binding transcription factors that interact with
members of the MyoD family to cooperatively activate
muscle specific genes. Embryonic hearts of Mef2a-defi-
cient mice and zebrafish show myofibrillar disarray, and
mice with skeletal muscle ablation of Mef2c form abnor-
mally assembled sarcomeres (Naya et al. 2002; Wang et
al. 2005; Potthoff et al. 2007).
In a genome-wide gene expression study of congenital
malformed human hearts we identified DPF3 as signifi-
cantly up-regulated in the right ventricular myocardium
of patients with Tetralogy of Fallot (TOF) (Kaynak et al.
2003). The study showed disease-associated expression
profiles for a panel of cardiac conditions in addition to
profiles specific for each cardiac chamber of the normal
human heart. DPF3 contains a double PHD finger con-
taining protein and a putative transcription factor. We
show that DPF3 is associated with the BAF complex, and
binds methylated and acetylated lysine residues of his-
tone 3 and 4. Thus, DPF3 contains the first PHD that
binds acetylated lysines, a feature previously only shown
for bromodomains. Furthermore, Dpf3 shows tissue-spe-
cific expression in heart and somites during develop-
ment of mouse, chicken, and zebrafish. Promoter analy-
sis identified Dpf3 as a novel downstream target of
Mef2a. Morpholino (MO) knockdown of dpf3 in zebra-
fish lead to severely reduced cardiac contractility, incom-
plete cardiac looping and defective organization of cardiac
and skeletal muscle fibers caused by transcriptional de-
regulation of structural and regulatory proteins essential
for muscle fibers. Taken together, DPF3 adds a further
layer of complexity to the BAF complex by representing a
tissue-specific anchor between histone acetylations as well
as methylations and chromatin remodeling.
Results
DPF3 is a muscle expressed member of the D4, zinc,
and double PHD finger family
DPF3 is an evolutionary highly conserved member of the
d4-protein family characterized by an N-terminal 2/3 do-
main unique to this protein family, a C2H2-type zinc
finger, and a C-terminal PHD zinc finger (Supplemental
Table S1; Natalia et al. 2001). DPF3 gives rise to two
splice variants (DPF3a and DPF3b) in human and mouse,
four in chicken, and one in zebrafish, with human and
mouse DPF3 differing only by one amino acid (Supple-
mental Fig. S1). The human DPF3b variant and the DPF3
full-length ortholog in zebrafish had not been identified
previously, and were cloned from human heart and ze-
brafish cDNA (AY803021, NM_001111169). DPF3 vari-
ants differ at the C terminus such that DPF3a encodes a
357-amino-acid protein containing a single truncated
PHD finger, while DPF3b consists of 378 amino acids
and a double PHD finger (Fig. 1A).
The other members of the d4 family are DPF1 and
DPF2. In the mouse, Dpf1 (Neud4) is expressed predomi-
nantly in the brain, and may have an important role in
developing neurons through regulation of cell survival as
DPF3—epigenetics of muscle development
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a neurospecific transcription factor (Lessard et al. 2007).
Dpf2 (ubi-d4/requiem) is ubiquitously expressed (Mert-
salov et al. 2000) and implicated to be required for cell
death after deprivation of trophic factors (Gabig et al.
1994).
We found both splice variants of DPF3 to be signifi-
cantly up-regulated in human right ventricular myocar-
dial tissue of TOF hearts compared with age- and gender-
matched samples obtained from hearts with single ven-
tricular septal defects as well as healthy donors (Fig.
1B,C). TOF represents a defect in heart looping and out-
flow tract formation characterized by a ventricular septal
defect, an overriding aorta, right ventricular outflow
tract stenosis and right ventricular hypertrophy second-
ary to hemodynamic stress, mainly due to increased
right ventricular systolic pressure. Using a multiple hu-
man tissue Northern blot we observed DPF3 to be spe-
cifically expressed in cardiac and skeletal muscle
(Fig. 1D).
DPF3a and DPF3b associate with BAF chromatin
remodeling complexes
DPF3 contains two PHD fingers, domains frequently
found in nuclear proteins whose substrate tend to be
nucleosomes (Bienz 2006). Using tandem affinity purifi-
cation technique (TAP) and mass spectrometry we iso-
lated potential nuclear binding partners of DPF3a and
DPF3b in HEK293T cells. We identified nearly all core
Figure 1. DPF3—a zinc and double PHD finger protein.
(A) Sequence conservation and divergence of human
DPF3 isoforms. DPF3a (AAX20019.1) and DPF3b
(NP_036206) contain an N-terminal 2/3 domain, a pu-
tative nuclear localization signal (NLS), a nuclear recep-
tor interaction domain (NID), and a C2H2-Krüppel-like
zinc finger. Note that the C-terminal double PHD is
truncated in DPF3a. Cysteine and histidine residues of
the PHDs are marked in bold. (B,C) Expression of DPF3
mRNA in malformed and normal human hearts. Real-
time PCR analysis of DPF3 mRNA levels in myocardial,
right ventricular tissue from patients with TOF, ven-
tricular septal defect (VSD), and healthy controls.
Analysis of splice variant-specific expression of DPF3a
and DPF3b in TOF patients and healthy controls. Ex-
pression values normalized to the housekeeping gene
HPRT. Statistically significant differences analyzed
by two-sided Wilcoxon test are indicated with asterisks
([*] P < 0.01; [**] P < 0.01). Scale bars represent ±SEM.
(D) Tissue-specific expression of DPF3 mRNA in hu-
mans analyzed by Northern blot. DPF3 mRNA expres-
sion is restricted to heart and skeletal muscle. The blot
containing mRNA from the indicated tissues was
probed with 32P-DPF3 cDNA (top panel), stripped, and
reprobed with 32P-Actin cDNA (bottom panel).
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components of the BAF chromatin remodeling complex
to be associated with both isoforms of DPF3 (Table 1).
We found that a very high percentage of proteins purified
with DPF3 correspond to the BAF complex (91.2% BAF
components with DPF3a and 86,8% with DPF3b as bait).
Among the interactors of DPF3a and DPF3b we found
SMARCD3, a heart and somite-specific subunit of the
complex. To confirm the association of DPF3 with the
BAF complex, we performed reverse-TAP and mass spec-
trometry using SMARCD3 as bait (Table 1). Thus, both
DPF3 isoforms associate with the BAF chromatin remod-
eling complex.
DPF3 interacts with methylated and acetylated lysine
residues of histones 3 and 4
It has recently become evident that proteins involved in
chromatin remodeling recognize specific modifications
on histone tails. The recognition of the methylation
state of lysine residues on histone 3 and 4 has been
shown to be mediated, among others, by the PHD,
whereas lysine acetylations are recognized by the bro-
modomain (Kouzarides 2007). To address whether DPF3
generally binds to histones, we used a glutathione-S-
transferase (GST) pull-down system and tested for the
Table 1. Human DPF3 protein interactions
Bait Alias HUGO ID
MW
(kDa)
Length
(amino acids)
Mascot
score
Spectral
counts
Sequence
coverage (%) NSAF
Accession
number
DPF3a BAF250A ARID1A 242.8 2285 1844 47 24 0.038 O14497
BAF250B ARID1B 237.1 2236 1171 33 14 0.027 Q8NFD5
BRG1 SMARCA4 185.0 1647 2196 51 29 0.057 P51532
BRM SMARCA2 181.3 1586 959 27 16 0.031 P51531
BAF170 SMARCC2 133.2 1214 2160 48 30 0.073 Q8TAQ2
BAF155 SMARCC1 123.2 1105 2401 49 38 0.081 Q92922
BAF60A SMARCD1 55.2 476 80 4 11 0.014 Q96GM5
BAF60B SMARCD2 52.7 456 846 23 44 0.093 Q92925
BAF60C SMARCD3 55.2 483 644 19 36 0.072 Q6STE5
BAF57 SMARCE1 46.7 411 982 19 49 0.085 Q969G3
BAF53 ACTL6A 47.9 429 826 17 39 0.073 O96019
BAF47 SMARCB1 44.4 385 659 14 39 0.067 Q12824
-actin ACTB 42.1 375 697 18 38 0.088 P60709
CERD4 DPF3 26.1 224 844 15 63 0.123 Q92784
DPF3b BAF250A ARID1A 242.8 2285 1461 49 27 0.036 O14497
BAF250B ARID1B 237.1 2236 457 16 9 0.012 Q8NFD5
BRG1 SMARCA4 185.0 1647 1912 43 22 0.044 P51532
BRM SMARCA2 181.3 1586 792 21 12 0.022 P51531
BAF170 SMARCC2 133.2 1214 1676 42 28 0.058 Q8TAQ2
BAF155 SMARCC1 123.2 1105 1511 42 29 0.064 Q92922
BAF60A SMARCD1 55.2 476 1062 26 45 0.091 Q96GM5
BAF60B SMARCD2 52.7 456 957 21 43 0.077 Q92925
BAF60C SMARCD3 55.2 483 616 19 37 0.066 Q6STE5
BAF57 SMARCE1 46.7 411 969 19 44 0.077 Q969G3
BAF53 ACTL6A 47.9 429 699 15 35 0.059 O96019
BAF47 SMARCB1 44.4 385 880 18 56 0.078 Q12824
-actin ACTB 42.1 375 604 18 43 0.080 P60709
CERD4 DPF3 26.1 224 909 16 63 0.120 Q92784
BAF60c BAF250A ARID1A 242.8 2285 680 46 23 0.046 O14497
BAF250B ARID1B 237.1 2236 375 30 12 0.031 Q8NFD5
BAF180 PBRM1 194.1 1689 91 9 5 0.012 Q86U86
BRG1 SMARCA4 185.0 1647 523 39 21 0.054 P51532
BRM SMARCA2 181.3 1586 195 20 10 0.029 P51531
BAF170 SMARCC2 133.2 1214 656 35 25 0.066 Q8TAQ2
BAF155 SMARCC1 123.2 1105 1069 42 36 0.087 Q92922
BAF60B SMARCD2 52.7 456 91 5 9 0.025 Q92925
BAF60C SMARCD3 55.2 483 202 14 19 0.066 Q6STE5
BAF57 SMARCE1 46.7 411 711 23 38 0.127 Q969G3
BAF53 ACTL6A 47.9 429 258 15 36 0.080 O96019
BAF47 SMARCB1 44.4 385 195 14 39 0.083 Q12824
-actin ACTB 42.1 375 398 13 37 0.079 P60709
CERD4 DPF3 26.1 224 72 2 11 0.021 Q92784
Peptides associated with DPF3a, DPF3b, and BAF60c identified by TAP and mass spectrometry. (MW) Calculated molecular weight;
(NSAF) Normalized spectral abundance factor (Florens et al. 2006).
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ability of recombinant full-length GST-DPF3 to pull
down histones from calf thymus extracts followed by
Western analyses using histone specific antibodies
against H2A, H2B, H3, and H4. DPF3b was able to pull
down histones H3 and H4 but not histones H2A and
H2B, whereas DPF3a did not bind any histones (Fig. 2A).
To further analyze if DPF3b binds specific histone modi-
fications through its PHD fingers, we tested a broad
panel of histone 3 and 4 peptides harboring specific
modifications such as methylations, acetylations, or
phosphorylations on different residues with pull-down
assays (Fig. 2B). Surprisingly, we observed specific binding
of DPF3b to acetylated lysines on histone 3 and 4
(H3K14ac, H3K9ac, H4K5ac, H4K8ac, H4K12ac, H4K16ac)
besides binding to mono- and dimethylated Lys 4 on his-
tone 3 (H3K4me1/2). Unmodified histone 3 and 4 and other
modifications were detected at the background level.
Since DPF3b contains a double PHD finger, we asked
whether the PHD1 or PHD2 alone is sufficient to recog-
nize histone lysine modifications. Pull-down assays re-
vealed that single DPF3-PHD fingers were sufficient for
the interaction with lysine acetylations on histone 4,
whereas histone 3 acetylations and methylations were
only recognized by the double PHD finger (Fig. 2B). Fur-
thermore, DPF3a, which only contains a truncated PHD
finger, did not bind any of the studied peptides. To sub-
stantiate these findings, we generated point mutations of
residues essential for the structural integrity of the aro-
matic cage formed by the PHD finger (W358E) as well as
residues that contribute to zinc-complexing (C360R/
C363R). These mutations lead to the abolishment of
single and double PHD finger binding to H3 and H4
modified peptides showing the specificity of the interac-
tions (Fig. 3B). The binding properties of DPF3-PHD fin-
gers were furthermore compared with the known meth-
yl- and acetyllysine recognition of the BPTF-PHD finger
and the BRG1 bromodomain.
Mapping of DPF3-binding sites reveals global
colocalization with histone modifications
by chromatin immunoprecipitation (ChIP)–chip
To obtain a global overview of potential downstream tar-
gets of DPF3, we used ChIP followed by array detection
Figure 2. The PHD fingers of DPF3b interact with modified histone tails on histone 3 and histone 4. (A) Pull-down assays followed
by Western blotting and immunodetection of indicated histones using GST-DPF3 fusion proteins and calf thymus histone extracts. (B)
Western blot analysis of histone peptide pulldowns with indicated GST-DPF3 fusion proteins and biotinylated peptides. GST-BPTF
and GST-BRG1 fusion proteins are shown as positive/negative controls. (Orange) GST tag; (green) DPF3-PHD1; (blue) DPF3-PHD2;
(purple) BPTF-PHD; (red) BRG1 bromodomain. (C) Co-occurrence of Dpf3, BRG1, H3K4me2, and H3ac/H4ac modifications on the
murine Pitx2 locus. Normalized and smoothed relative ChIP–chip intensities and position of real-time PCR primer are shown.
Lange et al.
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(ChIP–chip) and mapped the genomic localization of
DPF3-binding sites in C2C12 skeletal muscle cells. We
designed a custom muscle specific promoter array with
740,000 probes covering 10 kb upstream of and 3 kb
downstream from ∼12,000 transcripts. This array en-
abled analysis of our genes of interest with a much
higher degree of tiling and sequence coverage than stan-
dard whole-genome arrays would provide. We found a
total of 1201 transcripts in close distance to DPF3a- or
DPF3b-binding sites (460 and 979 respectively; 238
shared) (Supplemental Table S2). To gain first insight
into the functional role of downstream targets of DPF3,
we performed an analysis of GO terms and found that
DPF3 targets particularly play a role in cell proliferation,
nucleosome assembly, and chromatin remodeling
(Supplemental Table S3). Moreover, DPF3b targets are
especially important for cardiovascular development and
cytoskeleton organization. A number of DPF3 targets are
structural genes, like  actinin (Actn1), cardiomyopathy
associated 3 (Cmya3), myosin light chain (Myl1), and
troponin C (Tnnc1); muscle-regulating transcription fac-
tors and cofactors such as myocyte enhancer factor
(Mef2c/d), Cbp/p300-interacting transactivator (Cited2),
paired-like homeodomain transcription factor 2 (Pitx2),
four and a half LIM domains 2 (Fhl2), inhibitor of DNA
binding 2 (Id2); as well as genes essential for muscle dif-
ferentiation like bone morphogenetic protein 2 (Bmp2).
Figure 2C exemplifies observed binding sites of DPF3b
in the vicinity of target genes such as Pitx2. Moreover,
Pitx2 represents an example of co-occurrence of DPF3b-
binding sites with acetylated/methylated lysine residues
of histone 3 and 4, which have been analyzed by us pre-
viously (Fischer et al. 2008). To gain insight into the
frequency and relevance of DPF3b binding to histone 3
and 4 modification marks, we compared the two ChIP–
chip data sets. Out of 546 DPF3b-binding sites, 265 over-
lapped with histone 3 acetylation, 220 overlapped with
histone 4 acetylation, and 294 overlapped with histone 3
methylation marks. Thus, 66% of DPF3b-binding sites
overlap with acetylation marks and 54% with methyla-
tion marks, which is significantly more than one could
expect from random permutations (mininum 26%,
maximum 39%).
Co-occurrence of modified histones with DPF3
and BRG1 genomic binding sites
Considering that DPF3 is a member of the BAF chroma-
tin remodeling complex and binds modified histones, we
additionally analyzed the co-occurrence of DPF3-binding
sites with those of BRG1, a core component of the BAF
complex. To select potentially shared targets, we per-
formed ChIP–chip analysis for BRG1 in C2C12 cells
(data not shown). Using real-time PCR we screened 21
muscle relevant downstream targets for co-occurring
binding sites of modified histones, DPF3 and BRG1, and
observed a high degree of overlap (Table 2). This suggests
Figure 3. Expression patterns of Dpf3
mRNA during embryonic development
analyzed by in situ hybridization. Expres-
sion pattern of Dpf3 mRNA during mouse
(A), chicken (B), and zebrafish (C) develop-
ment is shown (ventral and lateral views
and closeups). (cc) Cardiac crescent; (ht)
heart tube; (v) ventricle; (ift) inflow tract;
(oft) outflow tract; (lv) left ventricle; (rv)
right ventricle; (la) left atrium; (ra) right
atrium; (som) somites; (st) septum trans-
versum; (mb) midbrain; (scl) sclerotome;
(pm) prechordal mesoderm; (fgp) foregut
pocket; (aip) anterior intestinal portal; (sv)
sinus venosus; (vv) vitelline veins; (a)
atrium; (nt) neural tube; (c) conus; (h)
heart; (v) ventricle; (skm) skeletal muscle;
(ov) optic vesicle.
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that DPF3 potentially serves as an anchor between the
BAF complex and modified histones.
Dpf3 expression patterns during embryonic
development
As DPF3 was up-regulated in hypertrophic cardiac tissue
of TOF patients, we were interested in its spatiotemporal
expression pattern during embryogenesis and performed
in situ hybridization in mouse, chicken, and zebrafish
embryos. Whole-mount in situ hybridization in mouse
embryos revealed cardiac and somite expression of
Dpf3a starting in the first differentiating cardiomyocytes
of the cardiac crescent at embryonic day 7.5 (E7.5) and in
the first somites at E8.0 (Fig. 3A). A detailed description
is provided in the Supplemental Material. Section in situ
hybridization revealed that Dpf3a expression was re-
stricted to the myocardial compartment of the heart (Fig.
3A). Further in situ hybridizations using a common Dpf3
probe revealed a similar expression pattern (data not
shown).
In order to analyze expression profiles of Dpf3a and
Dpf3b during later stages of heart development, real-
time PCR analysis was performed using cDNA obtained
from embryonic hearts extracted between E9.5 and E16.5
as well as P0 and adult hearts. Expression of Dpf3a and
Dpf3b was detectable from E9.5 onward, although Dpf3a
showedsubstantiallyhigherexpressionuntilE11.5,where
both splice variants subsequently reached a similar level
of expression that remained stable until birth and adult-
hood (Supplemental Fig. S2).
The expression patterns of Dpf1 and Dpf2 were also
analyzed by in situ hybridization in mouse embryos.
Dpf1 was predominantly expressed in the developing
brain, whereas Dpf2 was ubiquitously expressed (data
not shown).
In situ hybridization experiments in chicken embryos
using a probe targeting all splice variants of Dpf3 showed
conservation of the mouse Dpf3 expression pattern (Fig.
3B; see the Supplemental Material for a detailed descrip-
tion). In zebrafish embryos, dpf3 was strongly expressed
within the developing brain and throughout somitic tis-
sues along the entire length of the embryonic trunk and
tail shown by in situ hybridization at 36 and 72 h post-
fertilization (hpf) (Fig. 3C). Within the heart, dpf3 was
strongly expressed in the ventricle and faintly in the
atria. In the early embryo at 12 hpf, dpf3 is expressed
unspecifically. (Fig. 3C). Expression of dpf2 at 36 hpf is
within the developing brain and spinal cord (data not
shown), and in contrast to dpf3 was not detected in heart
or somites. This suggests that dpf3 is likely the only
muscle expressed d4 family member. Taken together,
these data demonstrate an evolutionarily conserved ex-
pression pattern of DPF3 orthologs.
Knockdown of dpf3 reveals its essential role
for heart and skeletal muscle development in vivo
To address the role of dpf3 in vivo, we performed MO
antisense oligonucleotide-mediated knockdown in ze-
brafish. We characterized embryos injected with MOdpf3,
which targets the exon4–intron4 boundary of dpf3 pre-
mRNA and blocks correct splicing. The specificity of the
MOdpf3 was demonstrated by coinjection of synthetic
Table 2. Co-occurrence of DPF3b with histone modifications and BRG1 binding
Gene Peak position Brg1 Dpf3b
Histone modificationsName Ensemble transcript ID Chr. Start End Fold change SD Fold change SD
Jmjd1c ENSMUST00000095573 10 66581196 66581787 18.00 0.12 7.12 0.10 H3ac
Ctnnb1 ENSMUST00000007130 9 120783627 120783820 5.84 0.09 3.79 0.08 H3ac, H3K4me2
Musk ENSMUST00000098059 4 58380142 58380250 5.25 0.17 3.27 0.06 H3ac, H3K4me2
Flrt2 ENSMUST00000057324 12 96093975 96094272 3.81 0.13 2.75 0.04 H3ac, H3K4me2
Gsk3b ENSMUST00000023507 16 38010138 38010438 6.07 0.14 2.54 0.04 H3ac, H3K4me2
Cald1 ENSMUST00000079391 6 34529598 34530598 11.44 0.19 2.36 0.12 H3ac, H3K4me2
Pten ENSMUST00000013807 19 32825230 32825724 2.16 0.14 2.16 0.30 H3ac, H3K4me2
Creb1 ENSMUST00000049932 1 64468558 64468747 2.09 0.12 1.84 0.05 H3ac, H3K4me2
Arpc2 ENSMUST00000006467 1 74172324 74172916 3.72 0.18 1.50 0.10 H3ac, H3K4me2
Sema3a ENSMUST00000095012 5 13405946 13406745 4.50 0.87 5.67 0.15 H3ac, H4ac
Zeb2 ENSMUST00000028229 2 44933122 44933520 6.23 0.30 6.71 0.20 H3ac, H4ac, H3K4me2
Trim23 ENSMUST00000022225 13 105298442 105298742 49.82 0.14 4.82 0.15 H3ac, H4ac, H3K4me2
Pitx2 ENSMUST00000029657 3 129193542 129193945 3.97 0.05 4.77 0.08 H3ac, H4ac, H3K4me2
Asb5 ENSMUST00000033918 8 56048828 56049632 13.41 0.48 4.05 0.11 H3ac, H4ac, H3K4me2
Foxp1 ENSMUST00000074346 6 99060857 99061758 10.99 0.02 2.94 0.11 H3ac, H4ac, H3K4me2
Csrp2 ENSMUST00000020403 10 110335474 110335974 8.03 0.17 2.06 0.09 H3ac, H4ac, H3K4me2
Cxcr7 ENSMUST00000065587 1 92036250 92036550 22.29 0.29 1.93 0.23 H3ac, H4ac, H3K4me2
Daam1 ENSMUST00000085299 12 72801340 72801838 10.00 0.09 2.73 0.12 H3K4me2
Igfbp5 ENSMUST00000027377 1 72811484 72812274 4.59 0.05 2.31 0.04 H4ac
Lamc1 ENSMUST00000027752 1 155062722 155063616 1.51 0.18 2.01 0.09 H4ac
Mtss1 ENSMUST00000080371 15 58894578 58895274 2.43 0.17 1.64 0.10 H4ac
Real-time PCR analysis showing cobinding of DPF3b and BRG1 at genomic sites that are further characterized by histone modifica-
tions. (SD) Standard deviation.
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and mature dpf3 mRNA, resulting in rescue of the
MOdpf3 phenotypes (Fig. 4). Efficacy of the MOdpf3 was
tested by PCR, which showed that the majority of dpf3
mRNA was incorrectly spliced leading to two truncated
proteins (Fig. 4A; Supplemental Material).
To assess cardiac morphogenesis and differentiation,
Figure 4. Knockdown of dpf3 in zebrafish and in C2C12 mouse skeletal muscle cells analysis of body and heart morphology in
embryos injected with MOdpf3 and controls at 36 hpf. (A) Knockdown of dpf3 lead to abnormal body posture (curved tail) in zebrafish
embryos. The phenotype could be rescued by coinjection of mature dpf3-mRNA. (Five independent experiments; embryos scored: 255
MO, 321 MO + rescue RNA; [*] P < 0.05; [**] P < 0.01.) (B) Analysis of heart morphology in [Tg(cmlcGFP)] zebrafish embryos.
Knockdown of dpf3 lead to abnormal heart looping, which could be rescued by coinjection of mature dpf3-mRNA. (Three independent
experiments; embryos scored: 101 MO, 145 MO + rescue RNA; [*] P < 0.05; [***] P < 0.001.) Statistical significance analyzed by
two-way ANOVA with Bonferroni post hoc testing. Scale bars represent ±SEM. (C) Analysis of isolated zebrafish hearts by confocal
microscopy. Cmlc marks all cardiomyocytes, S46 labels, the cells of the atrium, actin is predominantly expressed in the ventricle at
36 hpf. (D) In situ hybridization of chamber-specific markers amhc and vmhc. (E) In situ hybridization of left–right asymmetry marker
lefty2, and pitx2 as well as of differentially expressed genes hand2 and cmya1. (F) Analysis of skeletal muscle in wild-type, dpf3
morphant, and rescued embryos by immunohistochemistry at 36 hpf. (Top panel) Actin staining shows myofibrillar disarray and
transversion of somite boundaries. (Bottom panel) FAK staining reveals disruption of somite boundaries in dpf3 morphants. (G)
Disrupted sarcomere integrity in heart and skeletal muscle of dpf3 morphant embryos at 72 hpf shown by electron microscopy. Bar,
500 nm. (H) siRNA-mediated knockdown of Dpf3a and Dpf3 lead to defects in myofibrillar assembly in C2C12 mouse skeletal muscle
cells analyzed by electron microscopy. Bar, 500 nm.
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we used the MOdpf3 in a transgenic line of zebrafish that
expresses green fluorescent protein (GFP) under control
of the cardiac myosin light chain 2 (cmlc2) promoter
region [Tg(cmlc2:GFP)]. Injection of MOdpf3 at the one-
cell stage resulted in 91% of embryos with abnormal
heart morphology (n = 101) and in 74% of embryos with
a curved tail at 36 hpf (n = 255) (Fig. 4A,B). Consistent
with strong somitic expression of dpf3, MOdpf3-injected
embryos frequently displayed disturbed forward swim-
ming movements indicating skeletal muscle defects (Fig.
4A). Coinjection of synthetic full-length dpf3 mRNA
produced a significant rescue effect, with the percentage
of embryos with a dpf3 morphant body phenotype de-
creasing to 46% (n = 321, P < 0.01) and the heart pheno-
type decreasing to 63% (n = 145, P < 0.05) (Fig. 4A,B).
The heart phenotype was characterized by a thin and
elongated heart tube, with both ventricular and atrial
portions being affected. Moreover, looping of the heart
was strongly reduced and the atrioventricular boundary
was poorly defined in morphants (Fig. 4A,C). The
strength of ventricular and atrial contractility was weak-
ened compared with wild type, which resulted in slower
blood flow, supported also by a significantly reduced
ventricular shortening fraction (VSF) (P < 0.05) (data not
shown). Nevertheless, the heart beat rate was normal
(Supplemental Movies S1, S2). Both myocardial and en-
docardial layers were formed in morphant embryos, ex-
cluding defects in endocard–myocard signaling (data not
shown).
In order to characterize the cardiac phenotype more
thoroughly, we analyzed isolated hearts using confocal
microscopy and found that despite the weakly develop-
ing atrioventricular boundary and loss of heart looping,
atrial and ventricular myocyte specification was grossly
normal (Fig. 4C). Immunohistochemistry using the atrial
specific marker S46 showed that the atrium was clearly
separated from the ventricle (Yelon et al. 1999). This
finding was further confirmed by normal atrial myosin
heavy chain (amhc) and ventricular myosin heavy chain
(vmhc) expression at 72 hpf analyzed by in situ hybrid-
ization (Fig. 4D).
Dpf3 morphant zebrafish embryos display muscle
fiber disarray
To identify genes deregulated in dpf3 morphants, we per-
formed gene expression analysis (Affymetrix GeneChip
Zebrafish Genome Arrays) using RNA from whole dpf3
morphant embryos with severely reduced ventricular
contractility and control-injected stage-matched em-
bryos (n = 30, two replicates). Genes differentially regu-
lated with an adjusted P-value of <0.1 were selected
(1210 of ∼15,000 transcripts) for global functional analy-
sis based on overrepresented Gene Ontology terms
(Supplemental Table S4). The set of up-regulated genes
contained many genes essential for transcriptional regu-
lation, nucleosome assembly, and metabolic processes,
whereas genes involved in ion and electron transport
were overrepresented among down-regulated genes. A
subset of differentially expressed genes was confirmed by
real-time PCR including genes directly involved in sar-
comere assembly and muscle function that could explain
the cardiac and skeletal muscle phenotypes of dpf3 mor-
phants (Supplemental Table S5). We observed signifi-
cantly increased expression of cmya1 (fold change 2.9)
and of actin-binding protein 280-like (flncb; fold change
2.5). Furthermore, we found decreased expression of
heart and neural crest derivatives expressed 2 (hand2;
fold change 0.5), thymosin  (fold change 0.3), and a
novel protein (zgc:101755) similar to mouse actin fila-
ment capping protein of muscle Z-lines (fold change
0.5). However, as gene expression profiling was per-
formed using whole embryos, we further analyzed ex-
pression levels in situ. Figure 4E shows in situ hybrid-
ization analysis confirming the differential expression of
hand2 and cmya1. To test if the heart looping defects
were due to disturbed establishment of left–right asym-
metry in the embryo, asymmetrically expressed markers
left–right determination factor 2 (lefty2) and pitx2 were
analyzed revealing that left–right asymmetry was prop-
erly initiated.
To further evaluate the deregulation of sarcomeric pro-
teins we performed immunohistochemistry of morphant
muscle fibers in the zebrafish and found a grossly dis-
turbed actin organization compared with wild-type ani-
mals. The normal chevron-shaped somite organization
was lost and myofibers were misaligned. Frequently,
myofibers transversed somite boundaries. Focal adhe-
sion kinase (FAK) is a marker of somite boundaries. Im-
munohistochemistry using an antibody against FAK
showed disruption of somite boundaries (Fig. 4F). The
thickness of somites was also markedly reduced. The
specificity of this phenotype was confirmed by coinjec-
tion of synthetic full-length dpf3 mRNA together with
MOdpf3, which largely restored the myofiber organiza-
tion and somite boundary formation (Fig. 4F).
Using transmission electron microscopy, we found
that few myofibrils were present in dpf3 morphant ven-
tricles and skeletal muscle, which displayed a severe dis-
ruption of sarcomere assembly. Analysis of Dpf3 siRNA
knockdown in C2C12 mouse skeletal muscle cells
showed conservation of this phenotype (Fig. 4G,H) with
myofibrillar disarray compared with fiber aggregation in
cells treated with control siRNA.
Mef2a regulates Dpf3 expression in vivo
Mef2a-deficient mice and zebrafish embryos are pheno-
typically similar to the observed myofibrillar disarray in
dpf3 knockdown embryos (Naya et al. 2002; Wang et al.
2005; Potthoff et al. 2007). Consequently, we screened
the Dpf3 proximal promoter for potential Mef2-binding
sites. Within a conserved 1.2kbp promoter region we
found three Mef2 matrices using TRANSFAC MATCH
with stringent settings (Fig. 5A; Kel et al. 2003). Mef2a
ChIP–chip analysis in mouse cardiomyocytes (HL-1
cells) showed a significant peak of Mef2a binding in the
Dpf3 promoter region that could also be confirmed by
real-time PCR (1.8-fold change) (Fig. 5A). Knockdown of
Mef2a in HL-1 cells using two different siRNAs led to a
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reduction of Dpf3 expression of up to 40%, demonstrat-
ing that Mef2a functionally binds the Dpf3 promoter and
activates its expression (Fig. 5B,C). Transcriptional regu-
lation of Dpf3 by Mef2a was also tested in luciferase
reportergene assays using promoter fusion constructs of
a previously characterized DPF3 core promoter (M.
Lange and S. Sperling, unpubl.) and four consecutive re-
peats of the putative Mef2-binding sites. Cotransfections
in HEK293T cells revealed an activation of the core pro-
moter by Mef2a, which was additionally enhanced by
the Mef2.1-binding site, supporting a role for Mef2a as a
regulator of Dpf3 through combinatorial effects on the
Mef2.1 and Mef2.3 sites (Fig. 5D).
Discussion
Targeting of the BAF chromatin remodeling complex
to specific chromatin sites
A central question regarding the action of chromatin re-
modeling complexes is how they are recruited to their
target nucleosomes at specific positions within the ge-
nome. Most likely two mechanisms, the guidance by
DNA-binding transcription factors and the binding to
acetylated histone tails, play a central role (Peterson and
Workman 2000; Hassan et al. 2001). Both transcription
factor-binding sites as well as acetylated histones do not
occur exclusively in conjunction with actively tran-
scribed genes; thus, potentially, the interplay and co-oc-
currence of both might be essential for directed and tis-
sue-specific gene transcription. Here, we present DPF3,
which contains the first PHD fingers shown to bind
acetylated in addition to methylated histone residues.
Moreover, DPF3 links these modifications to the BAF
chromatin remodeling complex and displays an essential
role for skeletal and cardiac muscle development and
function in vivo. The tissue-specific expression of DPF3
in combination with the specific read-out of modified
histone residues allows for a side-directed recruitment of
the BAF chromatin remodeling complex, similar to that
of DNA-binding transcription factors.
The high impact of the modification status of histones
(acetylation/deacetylation) on transcription and on the
phenotype is well characterized; e.g., class II HDACs
control cardiac growth and gene expression in response
to stress stimuli (Backs and Olson 2006). DPF3 poten-
tially represents the missing link to explain the high
impact of the histone modification status on the recruit-
ment of the BAF complex to chromatin target sites. So
far, only bromodomains, frequently found in core and
subunit proteins of chromatin remodeling complexes,
have been shown to recognize histone acetylation
marks.
Using ChIP we show on a global scale that DPF3 binds
distinct chromatin sites in vivo, which are furthermore
essential for muscle development and function, and
marked by acetylated and/or methylated histones. It
would be interesting to analyze if DPF3 is also associated
with histone-modifying enzymes through the BAF com-
plex or other interaction partners. Thus, the binding of
DPF3 would be followed by a change in the histone
modification status, building a regulatory feedback loop.
Figure 5. Mef2a regulates DPF3 expression. (A) ChIP followed
by chip analysis shows binding of Mef2a to an evolutionary
conserved region of the Dpf3 promoter in vivo. Mef2a matrices
obtained by TRANSFAC MATCH are indicated. Conservation
of promoter sequence is shown. The Dpf3 core promoter indi-
cated is a minimal sufficient region required for transcriptional
activity. (B) Knockdown of Mef2a in HL-1 cells using two dif-
ferent siRNAs. Knockdown efficiency was analyzed by real-
time PCR and Western blot. (siNon) Nonspecific/scrambled.
(C) Knockdown of Mef2a in HL-1 cells lead to reduced expres-
sion of Dpf3 and Dpf3a. (siNon) Nonspecific/scrambled;
(*) P < 0.05; (**) P < 0.01; (***) P < 0.001. (D) Luciferase report-
ergene assay using the DPF3 core promoter alone or in combi-
nation with four repeats of the conserved, putative Mef2-bind-
ing sites (Mef2.1, Mef2.2, Mef2.3) fused to luciferase. Activity of
the reporter was measured alone or in cotransfections with
Mef2a/Mef2c expression vectors in HEK293T cells.
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The PHD of DPF3 binds modified histone lysine
residues
PHDs are frequently found in nuclear proteins, and are
defined by a stretch of ∼60 amino acids containing con-
served cysteine and histidine residues (C4-H-C3) that co-
ordinate two zinc ions forming interweaved zinc fingers
bridged by two small -strands (Bienz 2006). They are
known to serve as a protein–protein interaction domain
and bind nuclear phosphoinositides as well as nucleo-
somes (Bienz 2006; Ruthenburg et al. 2007). Moreover, in
a proteome-wide screen, only eight out of 18 PHD fingers
showed specific histone methyl-lysine interactions, in-
dicating additional roles for the PHD (Shi et al. 2007).
We report that the double PHD finger of DPF3 inter-
act with acetylated as well as methylated histone
tail residues, namely acetylated lysines on histones 3
and 4 (H3K9ac, H3K14ac, H4K5ac, H4K8ac, H4K12ac,
H4K16ac) and mono- and dimethylated lysine on histone
3 (H3K4me1/me2). Interestingly, single PHD fingers of
DPF3 only recognize histone 4 acetylation and an intact
PHD finger is necessary for histone interactions, as the
truncated PHD1 of DPF3a is not capable of binding any
histones.
So far, single PHD fingers have been shown to recog-
nize methylated histones; e.g., the PHD fingers of BPTF
and ING2 (Shi et al. 2006; Wysocka et al. 2006) bind
H3K4me with increasing affinity according to methyla-
tion status, while BHC80-PHD recognizes unmodified
H3K4 (Lan et al. 2007). Moreover, methylation at differ-
ent residues, namely H3 methylated at both Lys 4 and
Arg 2, can be read simultaneously by a single PHD of
RAG2, revealing additional complexity in the readout of
combinatorial modifications (Ramon-Maiques et al.
2007). Further experiments are needed to answer the
question if binding of acetylation and methylation
marks by the double PHD finger of DPF3 can occur si-
multaneously, which would allow a combinatorial read-
out of different modifications.
The finding that H3 modifications are only recog-
nized by the double PHD finger may be due to the
interweaved nature of the PHD finger. The domain nec-
essary for H3K4me1/me2 and H3ac recognition might
be a compound in which amino acids from PHD1
and PHD2 contribute to the three-dimensional struc-
ture.
Histone methyl-lysine-binding properties similar to
DPF3 have been described for the malignant brain tumor
(MBT) domain of L3MBTL1 and a mutated form of BPTF-
PHD, which also specifically recognize H3K4me1/me2.
Although structurally unrelated, both domains achieve
methyl-lysine binding through formation of a cage con-
sisting of aromatic residues (H. Li et al. 2007; Min et al.
2007). The PHD fingers of DPF3 contain several aro-
matic residues that can potentially contribute to the for-
mation of an aromatic cage, although a conserved tryp-
tophan is missing.
Further experiments using crystallography and NMR
spectroscopy will determine the structural basis for the
histone tail recognition by DPF3.
Role of DPF3 in heart and skeletal muscle
development
The up-regulated expression of DPF3 in patients with
TOF, a congenital heart defect in part characterized by
muscular hypertrophy, prompted us to investigate its
role during development and muscle differentiation.
Knockdown in zebrafish embryos and RNAi in mouse
skeletal muscle cells revealed an essential role of Dpf3 in
muscle cell differentiation.
In morphant embryos, we frequently observed myofi-
brillar disarray, transversion of the somite boundary by
actin filaments, and disruption of somite boundary for-
mation. In particular, the z-disc of sarcomeres represent-
ing the lateral boundaries where titin, nebulin, and the
thin filaments are anchored (Clark et al. 2002), appeared
to be affected. This phenotype could be explained by the
deregulation of several genes essential for muscle fiber
function shown by our expression studies—e.g., capZ
-1 (zgc:101755) and tropomodulin 4 (Schafer et al. 1995;
Sussman et al. 1998)—the actin-binding protein filamin
c  b (flncb) and its interaction partner cmya1. Filamin
C-knockout mice display severe defects in myogenesis,
including loss of distinct z-discs (Dalkilic et al. 2006),
while Cmya1--null mouse hearts show intercalated
disc disruption and myofilament disarray (Gustafson-
Wagner et al. 2007). Further, dpf3 morphants frequently
displayed impaired cardiac contractility, which may be
due to the strong up-regulation of troponin I. Notably,
mice expressing mutated versions of Troponin I display
hypercontractility (James et al. 2000), mirror imaging the
dpf3 morphant phenotype.
The morphant phenotype was also characterized by
disturbed heart looping and a poorly defined AV bound-
ary. Initial microarray analyses point to the deregulation
of transcription factors and extracelluar matrix mol-
ecules implicated in heart looping and left–right asym-
metry (data not shown). These molecules will be subject
to further studies on the role of dpf3 in early heart de-
velopment. Notably, knockdown of Smarcd3, the DPF3
interaction subunit of the BAF complex, also affects
heart looping in mouse and zebrafish by influencing
Notch signaling (Takeuchi et al. 2007). Moreover, Bmp2,
a gene essential for development of the AV cushions (Ma
et al. 2005) is a target of Dpf3 in C2C12 cells analyzed by
ChIP, and has been shown to be upstream of mef2a in
zebrafish in a pathway controlling cardiac contractility
(Wang et al. 2007).
Interestingly, the dpf3 morphant phenotype resembles
in part the defects seen in mef2a morphants and Mef2a-
deficient mice (Naya et al. 2002; Wang et al. 2005). As
our experiments show that Mef2a regulates Dpf3, it is
suggestive that the Mef2a phenotypes are partially
caused by loss of Dpf3 function. In the future, it will be
interesting to test the influence of Dpf3 on the Mef2a
phenotypes in mouse and zebrafish in detail.
Despite the strong expression of dpf3 in neuronal cells,
we did not observe any obvious malformations of the
brain. It has been shown recently that Dpf3a and Dpf1
seem to have overlapping functions during differentia-
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tion of neurons (Lessard et al. 2007). It is likely that Dpf1
may compensate for the loss of Dpf3 there, while expres-
sion in striated muscle appears exclusive to Dpf3.
We report that DPF3 contains the first PHDs known to
bind acetylated as well as methylated histone residues,
interacts with the BAF complex, and has an essential
role for muscle development and function. It is tempt-
ing to speculate that DPF3a and DPF3b might serve as
tissue-specific BAF subunits that regulate the transition
of muscle precursors to differentiating myocytes. More-
over, it is highly suggestive that other PHD fingers might
be capable to bind acetylation marks and play a yet un-
appreciated role in recruiting chromatin remodeling
complexes.
Materials and methods
Detailed procedures are provided in the Supplemental Material
Samples and preparation
Human cardiac samples were obtained from the German Heart
Center and treated as described (Kaynak et al. 2003). Mouse
embryonic and adult hearts were dissected from the rest of the
body at indicated stages and handled as human samples.
Gene expression analyses
Real-time PCR analysis was performed using SYBR Green I PCR
Master Mix (Abgene) and the ABI PRISM 7900HT Sequence
Detection System. Primer sequences are given in Supplemental
Table S6. In situ hybridization in mouse, chicken, and zebrafish
embryos was carried out as described (Wilkinson and Nieto
1993; Jowett and Lettice 1994). A multiple tissue human North-
ern blot (NTM 12, Clontech) was hybridized with a 32P-labeled
cDNA probe against DPF3 (AY803021; 7–423 bp) according to
the manufacturers’ instructions.
Affymetrix GeneChip Zebrafish Genome Arrays were hybrid-
ized with labeled cDNA obtained from total RNA of MO-dpf3
and MO-control-injected zebrafish embryos 72 hpf. Four chips
were hybridized (two MO-control, two MO-dpf3, 30 embryos
each) (www.ebi.ac.uk/arrayexpress, E-TABM-354). Data were
normalized via qspline after MAS background correction using
the Bioconductor affy package and the zebrafish annotation
package. Differentially expressed genes were calculated via the
limma package. P-values were adjusted for multiple testing us-
ing the Benjamini and Hochberg method. Genes with an ad-
justed P-value of <0.1 were defined as differentially expressed.
Antisense oligonucleotide MO and rescue experiments
Full-length zebrafish dpf3 (NM_001111169) was cloned into the
pCS2+ expression vector and used as rescue construct. Con-
structs were transcribed using the SP6 MessageMachine kit
(Ambion). For functional and rescue experiments, wild-type
Tuebingen LF/AB hybrids; Tg(cmlc2:GFP) transgenic fish em-
bryos were injected with ∼75 pg of mRNA. MOs (GeneTools)
were injected at a concentration of 100 µmol/L.
Confocal and live-stream imaging
Confocal images and z-stacks were obtained using the Zeiss
Meta 510 confocal microscope with a 40× lens and 1× zoom. For
live-stream imaging, Tg(cmlc2:GFP) transgenic embryos were
prepared as described (Westerfield 1994). Myocardial contrac-
tion and beating of the developing heart tube was imaged with
a CoolSnap ES camera (Photometrics) on an Axioplan2 micro-
scope.
Immunohistochemistry and transmission electron
microscopy
Antibody staining was performed as described previously
(Huang et al. 2003). Zebrafish electron micrographs were ob-
tained essentially as described (Rottbauer et al. 2001). C2C12
cells were grown on Thermanox coverslips (13 mm ø; Nunc) and
embedded in Spurr’s resin. Sixty-nanometer sections were ob-
served using Philips CM100 at 100 kV (FEI Company) with a
TVIPS Fastscan CCD camera (Tietz Systems).
Proteomic analyses
GST-DPF3 fusion proteins were created using the pGEX3x vec-
tor, expressed in Escherichia coli BL21 DE3 pRARE and purified
using glutathione-sepharose matrix (Amersham) according to
the manufacturer’s instructions.
For histone peptide-binding assays, 1 µg of biotinylated his-
tone peptide (Upstate Biotechnologies, and kind gifts of D. Patel
and D. Allis) was incubated with 1 µg of purified GST fusion
protein in binding buffer (50 mM Tris-HCl 7.5, 300 mM NaCl,
0.1% NP-40, 50 µM ZnAc) overnight at 4°C with rotation.
Streptavidin beads (Dynabeads) were added and incubated for 1
h at 4°C with rotation followed by four rounds of 15 min wash-
ing in binding buffer. Bound proteins were analyzed on SDS-
PAGE gels and subjected to immunoblotting analysis.
TAP was performed essentially as described (Gingras et al.
2005). Full-length DPF3a, DPF3b, and SMARCD3 was cloned
into the pcDNA3-NTAP vector, verified by sequencing, and
transfected into HEK293T cells.
siRNA knockdown experiments
C2C12 or HL-1 cells were seeded in six-well plates and trans-
fected with 4.4 µL of 20 µm siRNA (Supplemental Table S7).
siRNAs targeting Dpf3a (Invitrogen), both splice variants of
Dpf3 (Qiagen), or a control siRNA (AllStars Negative Control
siRNA, Qiagen) were used in C2C12, and siRNAs targeting
Mef2a in HL-1 cells. XtremeGene (Roche) and Lipofectamine
Plus (Invitrogen) were used for transfection according to manu-
facturer’s protocol and cultivated for 48 h. Cells were subse-
quently subjected to electron microscopy or microarray gene
expression analysis.
ChIP with chip detection (ChIP–chip)
C2C12 myoblasts cells were used either untransfected or trans-
fected with Flag-empty, Flag-DPF3a or Flag-DPF3b expression
vectors using Lipofectamine Plus (Invitrogen) according to
manufacturers’ instructions (Supplemental Fig. S3). ChIP ex-
periments were performed in duplicate essentially as described
(Horak et al. 2002). For immunoprecipitation, mouse-M2-anti-
Flag (Sigma) antibody and Brg1 (Santa Cruz Biotechnologies,
sc-10768) antibodies were used at 10 and 5 µg/mL for C2C12
cells and rabbit anti-Mef2A (Santa Cruz Biotechnologies) at 2
µg/mL for HL-1 cells. Samples were labeled and hybridized ac-
cording to NimbleGen standard procedures on
custom designed muscle arrays (www.ebi.ac.uk/arrayexpress,
A-MEXP-893). Array analysis was performed as described (Toe-
dling et al. 2007). Enriched targets (23 sites) of the negative
control (Flag-empty) were subtracted from DPF3 ChIP data.
Data are deposited at www.ebi.ac.uk/arrayexpress (E-TABM-
362).
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Reporter gene assays
Reporter constructs were made by cloning four repeats of
the putative Mef2-binding site upstream of a 385-bp
(chr14:72,430,563–72,430,943) DPF3 minimal promoter into
the pGL3 basic vector (Promega). Transient cotransfections
were carried out in triplicates in 96-well plates in HEK293T
cells by transfecting 45 ng of reporter vector, 5 ng of Firefly
luciferase vector for internal normalization of transfection effi-
ciency, and 100 ng of the respective expression vectors. Activity
was measured by Dual-Luciferase Assay (Promega) after 48 h.
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